Profiles

Keywords
Last Name
Institution

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by John Segreti and Gordon Trenholme.

 
Connection Strength
 
 
 
2.077
 
  1. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis. 1998 Oct; 27(4):711-3.
    View in: PubMed
    Score: 0.234
  2. Prabaker K, Muthiah C, Hayden MK, Weinstein RA, Cheerala J, Scorza ML, Segreti J, Lavin MA, Schmitt BA, Welbel SF, Beavis KG, Trenholme GM. Pseudo-outbreak of Mycobacterium gordonae Following the Opening of a newly constructed hospital at a Chicago Medical Center. Infect Control Hosp Epidemiol. 2015 Feb; 36(2):198-203.
    View in: PubMed
    Score: 0.181
  3. Segreti J, Kraatz J, Goldman M, Trenholme GM. In vitro activity of FK-037. A parenteral cephalosporin. Diagn Microbiol Infect Dis. 1994 Nov; 20(3):175-9.
    View in: PubMed
    Score: 0.178
  4. Segreti J, Goodman LJ, Trenholme GM. In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile. Diagn Microbiol Infect Dis. 1993 Aug-Sep; 17(2):177-9.
    View in: PubMed
    Score: 0.163
  5. Segreti J, Kapell KS, Trenholme GM. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis. Diagn Microbiol Infect Dis. 1992 May-Jun; 15(4):371-3.
    View in: PubMed
    Score: 0.150
  6. Segreti J, Gootz TD, Goodman LJ, Parkhurst GW, Quinn JP, Martin BA, Trenholme GM. High-level quinolone resistance in clinical isolates of Campylobacter jejuni. J Infect Dis. 1992 Apr; 165(4):667-70.
    View in: PubMed
    Score: 0.149
  7. Sikka MK, Hayden MK, Pur S, Segreti J, Harris AA, Weinstein RA, Trenholme G. Microbiologic and clinical epidemiologic characteristics of the Chicago subset of a multistate outbreak of Serratia marcescens bacteremia. Infect Control Hosp Epidemiol. 2010 Nov; 31(11):1191-3.
    View in: PubMed
    Score: 0.135
  8. Segreti J, Nelson JA, Goodman LJ, Kaplan RL, Trenholme GM. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea. Antimicrob Agents Chemother. 1989 Aug; 33(8):1385-7.
    View in: PubMed
    Score: 0.124
  9. Segreti J, Gvazdinskas LC, Trenholme GM. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3):253-5.
    View in: PubMed
    Score: 0.122
  10. Segreti J, Kessler HA, Kapell K, Trenholme GM. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains. Diagn Microbiol Infect Dis. 1989 May-Jun; 12(3 Suppl):87S-88S.
    View in: PubMed
    Score: 0.122
  11. Segreti J, Kessler HA, Kapell KS, Trenholme GM. In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis. Antimicrob Agents Chemother. 1989 Jan; 33(1):118-9.
    View in: PubMed
    Score: 0.119
  12. Segreti J, Kessler HA, Kapell KS, Trenholme GM. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. Antimicrob Agents Chemother. 1987 Jan; 31(1):100-1.
    View in: PubMed
    Score: 0.104
  13. Segreti J, Trenholme GM. Respiratory pharmacology. Antibiotics. I. Beta-lactam antibiotics, the tetracyclines, chloramphenicol, erythromycin, clindamycin, metronidazole, and the quinolones. Clin Chest Med. 1986 Sep; 7(3):393-412.
    View in: PubMed
    Score: 0.101
  14. Fischer SA, Harris AA, Segreti J, Goodman LJ, Langkop C, Swartz M, Lollar R, Trenholme GM. Screening for Escherichia coli O157:H7 in Illinois. Clin Microbiol Infect. 1996 Mar; 1(3):175-178.
    View in: PubMed
    Score: 0.049
  15. Segreti J, Trenholme GM, Levin S. Antibiotic therapy in the allergic patient. Med Clin North Am. 1995 Jul; 79(4):935-42.
    View in: PubMed
    Score: 0.047
  16. Glick EJ, Segreti J, Goodman LJ, Trenholme GM. In vitro activity of tosufloxacin against bacterial enteric pathogens. Diagn Microbiol Infect Dis. 1990 Jul-Aug; 13(4):333-6.
    View in: PubMed
    Score: 0.033
  17. Benson C, Segreti J, Kessler H, Hines D, Goodman L, Kaplan R, Trenholme G. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis. Eur J Clin Microbiol. 1987 Apr; 6(2):173-8.
    View in: PubMed
    Score: 0.026
  18. Benson CA, Segreti J, Beaudette FE, Hines DW, Goodman LJ, Kaplan RL, Trenholme GM. In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother. 1987 Feb; 31(2):328-30.
    View in: PubMed
    Score: 0.026
  19. Goodman LJ, Trenholme GM, Kaplan RL, Segreti J, Hines D, Petrak R, Nelson JA, Mayer KW, Landau W, Parkhurst GW, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med. 1990 Mar; 150(3):541-6.
    View in: PubMed
    Score: 0.008
  20. Fliegelman RM, Petrak RM, Goodman LJ, Segreti J, Trenholme GM, Kaplan RL. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother. 1985 Mar; 27(3):429-30.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.